{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:55Z","timestamp":1793383015955,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"am","delay-in-days":249,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH114908-01"],"award-info":[{"award-number":["R01MH114908-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS086749"],"award-info":[{"award-number":["T32NS086749"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017463","name":"School of Dental Medicine, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.neuropharm.2023.109587","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T15:29:44Z","timestamp":1685633384000},"page":"109587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Long-term \u03b15 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition"],"prefix":"10.1016","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3678-9907","authenticated-orcid":false,"given":"Jessica L.","family":"Nuwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-8391","authenticated-orcid":false,"given":"Nadya","family":"Povysheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8288-7885","authenticated-orcid":false,"given":"Tija C.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109587_bib1","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1073\/pnas.0800946105","article-title":"NMDA receptors inhibit synapse unsilencing during brain development","volume":"105","author":"Adesnik","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib2","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1111\/ejn.14841","article-title":"GSK-3\u03b2 regulates the synaptic expression of NMDA receptors via phosphorylation of phosphatidylinositol 4 kinase type II\u03b1","volume":"54","author":"Amici","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/dmd.105.006973","article-title":"Rat pharmacokinetics and pharmacodynamics of a sustained release formulation of the GABAA alpha5-selective compound L-655,708","volume":"34","author":"Atack","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2023.109587_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186147","article-title":"Functional characterization of GABAA receptor-mediated modulation of cortical neuron network activity in microelectrode array recordings","volume":"12","author":"Bader","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109587_bib6","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.celrep.2015.12.002","article-title":"Bidirectional control of synaptic GABAAR clustering by glutamate and calcium","volume":"13","author":"Bannai","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/dneu.22280","article-title":"Synaptic localization of \u03b15 GABA (A) receptors via gephyrin interaction regulates dendritic outgrowth and spine maturation","volume":"75","author":"Brady","year":"2015","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2017.10.022","article-title":"Depolarizing, inhibitory GABA type A receptor activity regulates GABAergic synapse plasticity via ERK and BDNF signaling","volume":"128","author":"Brady","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib9","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s00018-013-1550-7","article-title":"Neuronal calcium signaling: function and dysfunction","volume":"71","author":"Brini","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib10","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41386-020-0772-2","article-title":"Mechanisms associated with the antidepressant-like effects of L-655,708","volume":"45","author":"Bugay","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib11","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1523\/JNEUROSCI.14-09-05471.1994","article-title":"The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition","volume":"14","author":"Buller","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1152\/jn.1993.70.5.1841","article-title":"NMDA receptor-mediated components of miniature excitatory synaptic currents in developing rat neocortex","volume":"70","author":"Burgard","year":"1993","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib13","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.0307231101","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib14","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1523\/JNEUROSCI.2063-04.2004","article-title":"Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane","volume":"24","author":"Caraiscos","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","article-title":"Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects","volume":"20","author":"Carreno","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.911020","article-title":"The yin and yang of gabaergic and glutamatergic synaptic plasticity: opposites in balance by crosstalking mechanisms","volume":"14","author":"Chapman","year":"2022","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109587_bib18","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib19","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib20","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1016\/j.celrep.2019.02.070","article-title":"Nanoscale subsynaptic domains underlie the organization of the inhibitory synapse","volume":"26","author":"Crosby","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2020.09.037","article-title":"Relocation of an extrasynaptic GABAA receptor to inhibitory synapses freezes excitatory synaptic strength and preserves memory","volume":"109","author":"Davenport","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109587_bib22","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1111\/ejn.13329","article-title":"Partial inactivation of GABAA receptors containing the \u03b15 subunit affects the development of adult-born dentate gyrus granule cells","volume":"44","author":"Deprez","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib23","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1152\/jn.1999.82.6.3286","article-title":"GABA(A) receptor-mediated miniature postsynaptic currents and alpha-subunit expression in developing cortical neurons","volume":"82","author":"Dunning","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","article-title":"Selective inhibition of extra-synaptic \u03b15-GABAA receptors by S44819, a new therapeutic agent","volume":"125","author":"Etherington","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib25","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.3567-14.2015","article-title":"GluN2B-Containing NMDA receptors regulate AMPA receptor traffic through anchoring of the synaptic proteasome","volume":"35","author":"Ferreira","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib26","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/hipo.20584","article-title":"Distinct alpha subunits of the GABAA receptor are responsible for early hippocampal silent neuron-related activities","volume":"19","author":"Giusi","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2023.109587_bib28","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1523\/JNEUROSCI.4751-07.2008","article-title":"Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?","volume":"28","author":"Glykys","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib29","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1152\/jn.01122.2005","article-title":"Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice","volume":"95","author":"Glykys","year":"2006","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib30","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1113\/jphysiol.2007.134460","article-title":"The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus","volume":"582","author":"Glykys","year":"2007","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2023.109587_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s11689-022-09418-0","article-title":"A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-\u03b15 NAM (basmisanil) on intellectual disability associated with Down syndrome","volume":"14","author":"Goeldner","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2023.109587_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2014.10.004","article-title":"Benzodiazepine-dependent stabilization of GABA(A) receptors at synapses","volume":"63","author":"Gouzer","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib34","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1038\/ncomms7872","article-title":"Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory","volume":"6","author":"Hausrat","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109587_bib35","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41598-019-38750-0","article-title":"Delayed treatment of \u03b15 GABAA receptor inverse agonist improves functional recovery by enhancing neurogenesis after cerebral ischemia-reperfusion injury in rat MCAO model","volume":"9","author":"He","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.neuron.2013.10.025","article-title":"AMPARs and synaptic plasticity: the last 25 years","volume":"80","author":"Huganir","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109587_bib37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.conb.2012.01.007","article-title":"Synaptic plasticity of NMDA receptors: mechanisms and functional implications","volume":"22","author":"Hunt","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136344","article-title":"Combined treatment with exercise and \u03b15GABAAR inhibitor promotes motor function recovery after intracerebral hemorrhage","volume":"766","author":"Inoue","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109587_bib39","doi-asserted-by":"crossref","first-page":"10469","DOI":"10.1523\/JNEUROSCI.2267-05.2005","article-title":"Gephyrin regulates the cell surface dynamics of synaptic GABAA receptors","volume":"25","author":"Jacob","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib40","doi-asserted-by":"crossref","first-page":"18595","DOI":"10.1073\/pnas.1204994109","article-title":"Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition","volume":"109","author":"Jacob","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib41","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1073\/pnas.0903943106","article-title":"GABA(A) receptor membrane trafficking regulates spine maturity","volume":"106","author":"Jacob","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib42","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/nn.2636","article-title":"Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95","volume":"13","author":"Jo","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2007.02.058","article-title":"Increase in AMPA receptor-mediated miniature EPSC amplitude after chronic NMDA receptor blockade in cultured hippocampal neurons","volume":"418","author":"Kato","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2023.109587_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fphar.2012.00061","article-title":"Physiology and pathology of calcium signaling in the brain","volume":"3","author":"Kawamoto","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib45","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fncel.2014.00424","article-title":"The heterogeneity in GABAA receptor-mediated IPSC kinetics reflects heterogeneity of subunit composition among inhibitory and excitatory interneurons in spinal lamina II","volume":"8","author":"Labrakakis","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib46","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","article-title":"NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors","volume":"23","author":"Lad\u00e9p\u00eache","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib47","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1113\/JP276187","article-title":"GABA beyond the synapse: defining the subtype-specific pharmacodynamics of non-synaptic GABAA receptors","volume":"596","author":"Lagrange","year":"2018","journal-title":"J. Physiol. (Lond.)"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2023.109587_bib48","doi-asserted-by":"crossref","first-page":"i73","DOI":"10.1093\/bja\/aet038","article-title":"Potentiation of GABAA receptor activity by volatile anaesthetics is reduced by \u03b15GABAA receptor-preferring inverse agonists","volume":"110","author":"Lecker","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2023.109587_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0169-328X(98)00144-2","article-title":"The \u03b15 subunit of the murine type A GABA receptor","volume":"59","author":"Liu","year":"1998","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109587_bib50","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.emboj.7600995","article-title":"Activated radixin is essential for GABAA receptor alpha5 subunit anchoring at the actin cytoskeleton","volume":"25","author":"Loebrich","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2023.109587_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fncel.2019.00163","article-title":"Diazepam accelerates GABAAR synaptic exchange and alters intracellular trafficking","volume":"13","author":"Lorenz-Guertin","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib52","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/s41380-020-0793-6","article-title":"Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling","volume":"26","author":"Luo","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109587_bib53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuron.2009.02.027","article-title":"Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach","volume":"62","author":"Lu","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109587_bib54","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bja.2020.11.032","article-title":"Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of \u03b15 subunit-containing \u03b3-aminobutyric acid type A receptors: implications for treating cognitive deficits","volume":"126","author":"Manzo","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2023.109587_bib55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1113\/jphysiol.2006.125609","article-title":"In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells","volume":"581","author":"Marchionni","year":"2007","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuropharm.2023.109587_bib56","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/ALN.0b013e3181bbc961","article-title":"Etomidate targets alpha5 gamma-aminobutyric acid subtype A receptors to regulate synaptic plasticity and memory blockade","volume":"111","author":"Martin","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib57","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","article-title":"Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory","volume":"30","author":"Martin","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib58","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1523\/JNEUROSCI.1203-12.2013","article-title":"Reducing GABAA \u03b15 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome","volume":"33","author":"Mart\u00ednez-Cu\u00e9","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/309261a0","article-title":"Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones","volume":"309","author":"Mayer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109587_bib60","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.7150\/thno.60190","article-title":"Attenuation of tonic inhibition prevents chronic neurovascular impairments in a Thy1-ChR2 mouse model of repeated, mild traumatic brain injury","volume":"11","author":"Mester","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2023.109587_bib61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuroscience.2019.12.033","article-title":"Priming of GABAergic long-term potentiation by muscarinic receptors","volume":"428","author":"Morales-Weil","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109587_bib62","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/307462a0","article-title":"Magnesium gates glutamate-activated channels in mouse central neurones","volume":"307","author":"Nowak","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109587_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108724","article-title":"Sustained treatment with an \u03b15 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission","volume":"197","author":"Nuwer","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Update. Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109587_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","article-title":"LTP inhibits LTD in the hippocampus via regulation of GSK3beta","volume":"53","author":"Peineau","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109587_bib67","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hipo.20654","article-title":"Distinct trafficking and expression mechanisms underlie LTP and LTD of NMDA receptor-mediated synaptic responses","volume":"20","author":"Peng","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2023.109587_bib68","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/ncomms4921","article-title":"Synaptic recruitment of gephyrin regulates surface GABAA receptor dynamics for the expression of inhibitory LTP","volume":"5","author":"Petrini","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109587_bib69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2016.08.006","article-title":"Effects of memantine on the excitation-inhibition balance in prefrontal cortex","volume":"96","author":"Povysheva","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109587_bib70","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1073\/pnas.1321774111","article-title":"Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses","volume":"111","author":"Pribiag","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib71","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0028-3908(96)00061-5","article-title":"[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit","volume":"35","author":"Quirk","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib72","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.devbrainres.2004.04.003","article-title":"Expression of alpha 5 GABAA receptor subunit in developing rat hippocampus","volume":"151","author":"Ramos","year":"2004","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109587_bib73","series-title":"StatPearls","article-title":"Ketamine","author":"Rosenbaum","year":"2018"},{"key":"10.1016\/j.neuropharm.2023.109587_bib74","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1038\/emboj.2012.109","article-title":"Activity-dependent phosphorylation of GABAA receptors regulates receptor insertion and tonic current","volume":"31","author":"Saliba","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2023.109587_bib75","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/s41467-018-06004-8","article-title":"Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear \u03b15-GABAA receptors","volume":"9","author":"Schulz","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109587_bib76","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1523\/JNEUROSCI.2723-18.2019","article-title":"Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of down syndrome","volume":"39","author":"Schulz","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib77","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1523\/JNEUROSCI.2520-05.2005","article-title":"Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus","volume":"25","author":"Scimemi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12974-020-01843-z","article-title":"Extrasynaptic CaMKII\u03b1 is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model","volume":"17","author":"Tang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2023.109587_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021328","article-title":"Gene expression changes in GABA(A) receptors and cognition following chronic ketamine administration in mice","volume":"6","author":"Tan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109587_bib80","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109587_bib81","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1523\/JNEUROSCI.5050-07.2008","article-title":"The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin","volume":"28","author":"Tretter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib82","article-title":"Negative allosteric modulation of gamma-aminobutyric acid A receptors at \u03b15 subunit-containing benzodiazepine sites reverses stress-induced anhedonia and weakened synaptic function in mice","author":"Troppoli","year":"2021","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109587_bib83","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/36103","article-title":"Activity-dependent scaling of quantal amplitude in neocortical neurons","volume":"391","author":"Turrigiano","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109587_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1073\/pnas.1011824108","article-title":"Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin","volume":"108","author":"Tyagarajan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2023.109587_bib85","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2009.11.005","article-title":"alpha5 Subunit-containing GABA(A) receptors mediate a slowly decaying inhibitory synaptic current in CA1 pyramidal neurons following Schaffer collateral activation","volume":"58","author":"Vargas-Caballero","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109587_bib86","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1007\/s12035-017-0675-3","article-title":"Decreasing the expression of GABAA \u03b15 subunit-containing receptors partially improves cognitive, electrophysiological, and morphological hippocampal defects in the Ts65Dn model of down syndrome","volume":"55","author":"Vidal","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib87","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1523\/JNEUROSCI.16-06-01982.1996","article-title":"Evidence for multiple AMPA receptor complexes in hippocampal CA1\/CA2 neurons","volume":"16","author":"Wenthold","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109587_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109960","article-title":"Distinct regulation of tonic GABAergic inhibition by NMDA receptor subtypes","volume":"37","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001812","article-title":"Sleep and wake cycles dynamically modulate hippocampal inhibitory synaptic plasticity","volume":"20","author":"Wu","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib90","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2021.05.020","article-title":"Induction of inhibitory synaptic plasticity enhances tonic current by increasing the content of \u03b15-subunit containing GABAA receptors in hippocampal pyramidal neurons","volume":"467","author":"Wyro\u015blak","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109587_bib91","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/ejp.1009","article-title":"Inhibition of \u03b15 subunit-containing GABAA receptors facilitated spinal nociceptive transmission and plasticity","volume":"21","author":"Xue","year":"2017","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2023.109587_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111217","article-title":"Trafficking of NMDA receptors is essential for hippocampal synaptic plasticity and memory consolidation","volume":"40","author":"Yang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2023.109587_bib93","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1038\/ncomms4230","article-title":"A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages","volume":"5","author":"Yu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109587_bib94","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for \u03b15 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2023.109587_bib95","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/jn.91203.2008","article-title":"GABAA receptor alpha5 subunits contribute to GABAA,slow synaptic inhibition in mouse hippocampus","volume":"101","author":"Zarnowska","year":"2009","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2023.109587_bib96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4103\/1673-5374.250621","article-title":"Inhibition of \u03b15 GABAA receptors has preventive but not therapeutic effects on isoflurane-induced memory impairment in aged rats","volume":"14","author":"Zhao","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuropharm.2023.109587_bib97","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1172\/JCI76669","article-title":"Sustained increase in \u03b15GABAA receptor function impairs memory after anesthesia","volume":"124","author":"Zurek","year":"2014","journal-title":"J. Clin. Invest."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:38Z","timestamp":1758439478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823001776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":97,"alternative-id":["S0028390823001776"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109587","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term \u03b15 GABA A receptor negative allosteric modulator treatment reduces NMDAR-mediated neuronal excitation and maintains basal neuronal inhibition","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109587"}}